Pharmacokinetics of Rytary(®), An Extended-Release Capsule Formulation of Carbidopa–Levodopa

Parkinson’s disease (PD) is a chronic progressive neurological disorder characterized by resting tremor, rigidity, bradykinesia, gait disturbance, and postural instability. Levodopa, the precursor to dopamine, coadministered with carbidopa or benserazide, aromatic amino acid decarboxylase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittur, Aravind, Gupta, Suneel, Modi, Nishit B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563351/
https://www.ncbi.nlm.nih.gov/pubmed/28236251
http://dx.doi.org/10.1007/s40262-017-0511-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563351/
https://www.ncbi.nlm.nih.gov/pubmed/28236251
http://dx.doi.org/10.1007/s40262-017-0511-y

Ejemplares similares